Lonza confident of 2020 target for Moderna Covid-19 vaccine supply

Lonza is confident that US and Swiss plants it is building to help make Moderna’s Covid-19 vaccine candidate will be ready for commercial production this year, executives at the Swiss company said on Tuesday.

Read Full Story>>